Poulton Jeffrey V.
EVP, Chief Financial Officer · 56 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 818 | $323.84 | $264,901.12 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 374 | $323.01 | $120,805.74 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 309 | $321.82 | $99,442.38 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 291 | $324.88 | $94,540.08 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 230 | $320.81 | $73,786.30 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 223 | $325.67 | $72,624.41 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 114 | $319.03 | $36,369.42 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 109 | $320.01 | $34,881.09 | filing |
| 2026-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Option exercise | 1,908 | $0.00 | $0.00 | filing |
| 2026-02-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 2,242 | $310.08 | $695,201.15 | filing |
| 2026-02-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 4,579 | $0.00 | $0.00 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 405 | $365.56 | $148,051.80 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 365 | $364.83 | $133,162.95 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 284 | $360.22 | $102,302.48 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 226 | $358.18 | $80,948.68 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 181 | $361.45 | $65,422.45 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 176 | $357.17 | $62,861.92 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 170 | $368.62 | $62,665.40 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 156 | $359.14 | $56,025.84 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 135 | $362.38 | $48,921.30 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 92 | $366.41 | $33,709.72 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 87 | $363.55 | $31,628.85 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 76 | $367.40 | $27,922.40 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 78 | $355.16 | $27,702.48 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 76 | $356.09 | $27,062.84 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 73 | $369.48 | $26,972.04 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 72 | $353.95 | $25,484.40 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 36 | $370.87 | $13,351.32 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 34 | $375.65 | $12,772.10 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 27 | $377.82 | $10,201.14 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 25 | $374.44 | $9,361.00 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 6 | $372.46 | $2,234.76 | filing |
| 2026-01-11 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 6,193 | $0.00 | $0.00 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 869 | $452.69 | $393,387.61 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 704 | $450.81 | $317,370.24 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 432 | $451.86 | $195,203.52 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 428 | $453.77 | $194,213.56 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 324 | $449.79 | $145,731.96 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 317 | $454.84 | $144,184.28 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 234 | $448.77 | $105,012.18 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 191 | $457.43 | $87,369.13 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 150 | $446.53 | $66,979.50 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 95 | $455.82 | $43,302.90 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 73 | $447.92 | $32,698.16 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 4 | $457.64 | $1,830.56 | filing |
| 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 3,108 | $0.00 | $0.00 | filing |
| 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 4,644 | $0.00 | $0.00 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 886 | $454.04 | $402,279.44 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 536 | $452.96 | $242,786.56 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 392 | $454.84 | $178,297.28 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 168 | $451.99 | $75,934.32 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 147 | $449.92 | $66,138.24 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 63 | $450.92 | $28,407.96 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 63 | $447.98 | $28,222.74 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 19 | $455.82 | $8,660.58 | filing |
| 2025-08-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 4,644 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.